MAIA Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Selling, General & Admin	9.07	6.14	4.29	5.56
Research & Development	11.11	8.93	3.5	1.41
Other Operating Expenses	0	1.1	0	0
Operating Expenses	20.18	16.18	7.79	6.98
Operating Income	-20.18	-16.18	-7.79	-6.98
Interest Expense / Income	0.01	0.01	0.83	0.03
Other Expense / Income	-0.42	0.04	3.89	-0.37
Pretax Income	-19.77	-16.22	-12.5	-6.64
Net Income	-19.77	-16.22	-12.5	-6.64
Shares Outstanding (Basic)	13	9	5	4
Shares Outstanding (Diluted)	13	9	5	4
Shares Change	42.95%	75.75%	19.23%	-
EPS (Basic)	-1.49	-1.75	-2.37	-1.50
EPS (Diluted)	-1.49	-1.75	-2.37	-1.50
Free Cash Flow	-13.07	-12.1	-4.12	-1.84
Free Cash Flow Per Share	-0.99	-1.30	-0.78	-0.42
EBITDA	-19.77	-16.21	-11.68	-6.6
EBIT	-19.77	-16.21	-11.68	-6.6

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).